MedTrace Logo

Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19

NCT04373148 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 316

Last updated 2022-06-15

No results posted yet for this study

Summary

The purpose of this study is to test over time immunity to SARS-CoV-2, a recently identified coronavirus responsible for the 2019 world-wide pneumonia outbreak known as COVID-19. Adults and children diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Conditions

  • Coronavirus

Interventions

OTHER

There is no intervention

There is no intervention

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • National Cancer Institute (NCI)

    collaborator NIH

  • National Institute of Environmental Health Sciences (NIEHS)

    collaborator NIH

  • Stanford University

    lead OTHER

Principal Investigators

  • Kari Nadeau, MD, PhD · Stanford University

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-08
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04373148 on ClinicalTrials.gov